Cue Health (NASDAQ:HLTH – Get Rating) was downgraded by analysts at The Goldman Sachs Group from a “buy” rating to a “neutral” rating in a research report issued on Friday, The Fly reports. Separately, BTIG Research decreased their target price on shares of Cue Health from $5.00 to $3.00 in a research note on Monday, […]